4399在线视频免费观看

吉林(lin)敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)藥(yao)(yao)業(ye)集團股份(fen)有(you)限公(gong)司創業(ye)之(zhi)初(chu)(chu)，集團領(ling)導(dao)秉(bing)承中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)“濟(ji)世救人”的(de)(de)(de)(de)(de)傳統提出 “制藥(yao)(yao)釀德(de)”的(de)(de)(de)(de)(de)企(qi)(qi)業(ye)價值觀，以世人健康為(wei)己任。新時期，全球經(jing)濟(ji)一(yi)體化(hua)(hua)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)產業(ye)將與(yu)(yu)世界接軌，順(shun)應國(guo)(guo)際(ji)藥(yao)(yao)品(pin)(pin)行業(ye)發(fa)(fa)展趨(qu)勢，敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)人重(zhong)視科(ke)技(ji)(ji)(ji)創新，引(yin)進(jin)(jin)科(ke)技(ji)(ji)(ji)人才，營(ying)建(jian)(jian)綠(lv)色無(wu)污染(ran)藥(yao)(yao)物資(zi)源，大(da)力(li)發(fa)(fa)展生(sheng)(sheng)態(tai)(tai)藥(yao)(yao)業(ye)，走中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)現代化(hua)(hua)之(zhi)路，參與(yu)(yu)國(guo)(guo)際(ji)競爭(zheng).“以人為(wei)本,以德(de)為(wei)先，善待生(sheng)(sheng)命，關注健康”的(de)(de)(de)(de)(de)企(qi)(qi)業(ye)理念，充分體現了吉林(lin)敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)的(de)(de)(de)(de)(de)人本主義思想，重(zhong)視技(ji)(ji)(ji)術(shu)(shu)(shu)創新，增(zeng)強企(qi)(qi)業(ye)綜合(he)競爭(zheng)實力(li)，顯示了敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)人再(zai)創輝煌的(de)(de)(de)(de)(de)經(jing)營(ying)策略(lve)和(he)(he)戰略(lve)思想。科(ke)技(ji)(ji)(ji)是(shi)企(qi)(qi)業(ye)發(fa)(fa)展的(de)(de)(de)(de)(de)第一(yi)生(sheng)(sheng)產力(li)，是(shi)決(jue)定企(qi)(qi)業(ye)在二十一(yi)世紀生(sheng)(sheng)存與(yu)(yu)發(fa)(fa)展的(de)(de)(de)(de)(de)關鍵因素，集團公(gong)司從建(jian)(jian)立(li)敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)制藥(yao)(yao)廠初(chu)(chu)期就意識到沒有(you)科(ke)研(yan)單位的(de)(de)(de)(de)(de)加盟，企(qi)(qi)業(ye)就難以在激烈的(de)(de)(de)(de)(de)市場競爭(zheng)中(zhong)(zhong)(zhong)(zhong)(zhong)立(li)足。多(duo)年來，集團與(yu)(yu)國(guo)(guo)內(nei)大(da)中(zhong)(zhong)(zhong)(zhong)(zhong)院校建(jian)(jian)立(li)了信(xin)息網絡，參與(yu)(yu)技(ji)(ji)(ji)術(shu)(shu)(shu)研(yan)究(jiu)，以現代疾(ji)病為(wei)開發(fa)(fa)方向(xiang),探討靶(ba)向(xiang)給藥(yao)(yao)、觸發(fa)(fa)釋藥(yao)(yao)系(xi)統等(deng)高新產品(pin)(pin),采用逆流動態(tai)(tai)提取、微粉技(ji)(ji)(ji)術(shu)(shu)(shu)、大(da)孔吸附(fu)技(ji)(ji)(ji)術(shu)(shu)(shu)等(deng)新工(gong)藝，提高臨床上(shang)量大(da)、面廣產品(pin)(pin)的(de)(de)(de)(de)(de)技(ji)(ji)(ji)術(shu)(shu)(shu)經(jing)濟(ji)指標。1998年被國(guo)(guo)家(jia)經(jing)貿委認(ren)定為(wei)技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心，成為(wei)企(qi)(qi)業(ye)技(ji)(ji)(ji)術(shu)(shu)(shu)進(jin)(jin)步和(he)(he)技(ji)(ji)(ji)術(shu)(shu)(shu)創新的(de)(de)(de)(de)(de)主要技(ji)(ji)(ji)術(shu)(shu)(shu)依托.并(bing)于2001年12月11日被國(guo)(guo)家(jia)人事部批準設(she)立(li)博士后(hou)工(gong)作站。在"十五"期間將要把吉林(lin)敖(ao)(ao)(ao)(ao)東(dong)(dong)(dong)技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心建(jian)(jian)設(she)成為(wei)新技(ji)(ji)(ji)術(shu)(shu)(shu)研(yan)究(jiu)開發(fa)(fa)中(zhong)(zhong)(zhong)(zhong)(zhong)心和(he)(he)產學研(yan)合(he)作交流中(zhong)(zhong)(zhong)(zhong)(zhong)心以及技(ji)(ji)(ji)術(shu)(shu)(shu)決(jue)策咨詢中(zhong)(zhong)(zhong)(zhong)(zhong)心。

重(zhong)視(shi)人才，重(zhong)視(shi)科技(ji)，建(jian)立完善(shan)技(ji)術創新(xin)體系(xi)

公司(si)地(di)(di)(di)(di)處我(wo)國五大(da)藥庫之一的(de)(de)長白(bai)山腹地(di)(di)(di)(di),同(tong)時擁有(you)100多畝山林藥材種植基(ji)(ji)(ji)地(di)(di)(di)(di)和(he)亞(ya)洲大(da)的(de)(de)純種梅花鹿(lu)養殖基(ji)(ji)(ji)地(di)(di)(di)(di)、保證了(le)原(yuan)料的(de)(de)地(di)(di)(di)(di)道(dao)純正。公司(si)依(yi)托“打破地(di)(di)(di)(di)域局(ju)限建立生(sheng)態藥業”的(de)(de)構想，先后建立了(le)六(liu)大(da)生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)，即中(zhong)成藥生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)、鹿(lu)系列(lie)產(chan)品生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)、生(sheng)化(hua)(hua)制劑生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)、化(hua)(hua)學合成藥生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)，中(zhong)藥材料生(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)。

自1996年重(zhong)組以來,公(gong)司(si)(si)董事(shi)(shi)會將企(qi)(qi)業技(ji)(ji)(ji)術(shu)(shu)(shu)創(chuang)新(xin)工(gong)(gong)作,作為(wei)企(qi)(qi)業發(fa)(fa)(fa)展的(de)(de)(de)一(yi)項戰略任務來抓(zhua)，成立了以公(gong)司(si)(si)董事(shi)(shi)長(chang)、副董事(shi)(shi)長(chang)、技(ji)(ji)(ji)術(shu)(shu)(shu)副總經理為(wei)核心(xin)(xin)的(de)(de)(de)企(qi)(qi)業技(ji)(ji)(ji)術(shu)(shu)(shu)創(chuang)新(xin)管委會，設(she)有(you)專(zhuan)職人員具體負責技(ji)(ji)(ji)術(shu)(shu)(shu)。1997年敖(ao)東(dong)藥(yao)業被吉林(lin)省(sheng)定(ding)為(wei)省(sheng)級企(qi)(qi)業技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin).該技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin)以企(qi)(qi)業現有(you)專(zhuan)業技(ji)(ji)(ji)術(shu)(shu)(shu)人員為(wei)主，聘(pin)請了國內十多所大(da)專(zhuan)院(yuan)校和科研(yan)單位的(de)(de)(de)60余名資深專(zhuan)家，下(xia)設(she)：中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)工(gong)(gong)程研(yan)究部、中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)新(xin)品(pin)種(zhong)(zhong)(zhong)開(kai)發(fa)(fa)(fa)部、生物技(ji)(ji)(ji)術(shu)(shu)(shu)開(kai)發(fa)(fa)(fa)部。每年公(gong)司(si)(si)從銷售收入(ru)中(zhong)(zhong)(zhong)(zhong)(zhong)提取1.5%研(yan)究開(kai)發(fa)(fa)(fa)經費，用于(yu)技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin)建設(she)，現已累(lei)計投入(ru)資金3000多萬(wan)元(yuan)，目(mu)前(qian)，該技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin)共完成老品(pin)種(zhong)(zhong)(zhong)改造2個(ge)(ge)(ge)，開(kai)發(fa)(fa)(fa)新(xin)藥(yao)56個(ge)(ge)(ge).取得新(xin)藥(yao)認證2個(ge)(ge)(ge)，儲備新(xin)藥(yao)品(pin)種(zhong)(zhong)(zhong)5個(ge)(ge)(ge)，仿制新(xin)品(pin)種(zhong)(zhong)(zhong)9個(ge)(ge)(ge)，工(gong)(gong)藝(yi)技(ji)(ji)(ji)術(shu)(shu)(shu)和外包裝被國家列入(ru)專(zhuan)利受理的(de)(de)(de)6個(ge)(ge)(ge)，列入(ru)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)保護品(pin)種(zhong)(zhong)(zhong)的(de)(de)(de)2個(ge)(ge)(ge)，列入(ru)國家火炬計劃的(de)(de)(de)1個(ge)(ge)(ge).近期，吉林(lin)敖(ao)東(dong)正在(zai)(zai)重(zhong)新(xin)修定(ding)規(gui)劃，對技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin)再投資5000萬(wan)元(yuan)進行(xing)二期改造,主要建設(she)3000平(ping)方米科研(yan)大(da)樓,1500平(ping)方米產品(pin)中(zhong)(zhong)(zhong)(zhong)(zhong)試樓，購置(zhi)78臺（套(tao)(tao)）各種(zhong)(zhong)(zhong)檢(jian)測儀器(qi)和配套(tao)(tao)設(she)備，項目(mu)建成后，將先(xian)期開(kai)發(fa)(fa)(fa)新(xin)品(pin)種(zhong)(zhong)(zhong)24項，晉升類別品(pin)種(zhong)(zhong)(zhong)14個(ge)(ge)(ge)。對于(yu)企(qi)(qi)業技(ji)(ji)(ji)術(shu)(shu)(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)(xin)研(yan)究開(kai)發(fa)(fa)(fa)的(de)(de)(de)成果，在(zai)(zai)公(gong)司(si)(si)內部實行(xing)統(tong)一(yi)運作，有(you)償轉讓。